SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-032216
Filing Date
2024-08-14
Accepted
2024-08-14 16:15:28
Documents
82
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 1155519
2 ex31-1.htm EX-31.1 11853
3 ex31-2.htm EX-31.2 11955
4 ex32-1.htm EX-32.1 7621
5 ex32-2.htm EX-32.2 7811
  Complete submission text file 0001493152-24-032216.txt   6080274

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfri-20240630.xsd EX-101.SCH 53655
7 XBRL CALCULATION FILE bfri-20240630_cal.xml EX-101.CAL 72512
8 XBRL DEFINITION FILE bfri-20240630_def.xml EX-101.DEF 243219
9 XBRL LABEL FILE bfri-20240630_lab.xml EX-101.LAB 400255
10 XBRL PRESENTATION FILE bfri-20240630_pre.xml EX-101.PRE 318719
84 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 831789
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 241208035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)